Hi, please summarize the following podcast episode, I am providing a transcript: 



Transcript
0:00
It's the Adam Ragusea podcast, episode 55  and we are talking today about incretin  
0:06
mimetics — the hot new pharmaceuticals that  mimic appetite and energy-regulating hormones  
0:13
naturally produced in your gut in response  to the food that you eat, or don't eat.
0:19
This is the new generation of anti-obesity,  anti-type-2-diabetes drugs you've probably  
0:25
been hearing about lately — Ozempic is the  brand name you're most likely to have heard  
0:31
at this point, but there's lots of others in  Big Pharma's big ol' money-sucking pipeline.
0:38
I'm not mad about it. For all the things that are  legit evil about large pharmaceutical companies,  
0:44
I reckon the interests of Big Pharma and  little me coincide more often than they  
0:50
conflict. When it comes to these drugs, I  say, shut up and take my money, Big Pharma.
0:57
"Mounjaro" is the unpronounceably stupid  brand name of another drug that looks  
1:04
even more promising than Ozempic, according to  studies on Mounjaro published this past week,  
1:10
that we're gonna read through in a minute.  NAME_1 is pushing for fast-track government  
1:16
approval of that one here in the U.S.  It's already approved for diabetes,   they're trying to get it approved for weight loss.
1:22
These drugs have been in the news for good reason. Based upon my layman's reading of the  scientific literature on this topic,  
1:30
and also on my probably much mo